PHARMALEX
ActiveSummary
PHARMALEX has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €64,882. Equity remains stable across the filed financial years (±2.3% per year). Its solvency ranks better than 87% of 1,068 sector peers (NACE 69, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Board 1
Permanent representatives 1
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| AMARRIS HOLDING.BE |
|
| CDP PETIT & Co |
|
| BERNARD Guy Ivan Marc |
|
| MEULEMAN Philippe Charles Louis |
|
Owners and capital
Owners
2 ownersChain of control
- AMARRIS HOLDING SASFR
- AMARRIS HOLDING.BE
- PHARMALEX
Highest known parent: AMARRIS HOLDING SAS (France). The sources do not say who stands above it.
Owners 2
-
100%
- AMARRIS HOLDING SASFRconsolidating parentconsolidates
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 03-08-2026 Capital stated in the act · 200 shares